Yelena Yankovskaya, PharmD, Discusses the Expectations and Roles of VBID in Combating Nonadherence
April 5th 2013Yelena Yankovskaya, PharmD, a managed markets fellow at the Mayes College of Healthcare Business and Policy, describes the expectations and roles of predictive modeling, value-based insurance design, and gamification/social media in contemporary managed care pharmacy.
Read More
In an educational symposium entitled, "The Evolution of Multiple Sclerosis Treatment: The Role of the Managed Care Pharmacist," Kristen Helms, PharmD, and her 2 colleagues discuss how treatments for multiple sclerosis (MS) have evolved over the past 2 decades, explore the novel and emerging therapeutic strategies for MS, and cover strategies to improve medication adherence for the chronic disease.
Read More
Daniel Tomaszewski, PharmD, Discusses How Practices in Managed Care Pharmacy Guided Legislation
April 5th 2013Daniel Tomaszewski, PharmD, PhD Candidate, an assistant professor at the University of Minnesota, College of Pharmacy, Duluth, discusses the impact of managed care pharmacy on current legislation, regulatory policies, and ongoing healthcare reform.
Read More
Eric Wright, PharmD, BCPS, Addresses How MMOTs Influence Current Managed Care
April 5th 2013Eric A. Wright, PharmD, BCPS, an investigator at the Geisinger Center for Health Research, discusses the implications of medical moments of truth (MMOTs) on current therapeutic and managed care strategies.
Read More
In an educational session satellite symposium entitled "Biologic Therapies for Chronic Diseases: Factors Influencing Treatment Decisions," Robert P. Navarro, PharmD, along with his colleagues, delves into the current trends of specialty pharmacy and biological therapies, and how managed care discussions have evolved to optimize patient outcomes within a cost-constrained healthcare environment.
Read More
Rebecca P. Snead, RPh, Discusses the Current Movement Toward Pharmacist Provider Status
April 5th 2013Rebecca P. Snead, RPh, the executive vice president and CEO of the National Alliance of State Pharmacy Associations, discusses the current movement toward pharmacist provider status, and elaborates on the challenges and opportunities encountered.
Read More
In an educational seminar entitled "How Much of the $3 Billion in Star Rating Bonuses Did Your MCO Capture?," David Nau, RPh, PhD, CPHQ, FAPhA, along with his colleagues, discussed Medicare star ratings and how managed care organizations have implemented practices and processes to ensure the delivery of high-quality care to their members.
Read More
Optimizing Managed Care Strategies Amidst a Growing Orphan Drug Pipeline
April 5th 2013Mattias Cheung, PhD, FCSHP, FASHP, discusses the ongoing progress of orphan drugs for rare diseases in today's health care environment, and explores their challenges and opportunities in the current managed care landscape.
Read More
Matthias Cheung, PhD, FCSHP, FASHP, a principal at Advanced Rx Consulting, LLC, and an adjunct professor of pharmacy practice at the University of the Pacific, Thomas J. Long School of Pharmacy and Health Services, discusses the circumstances and factors that catalyzed the passage of current legislation and regulatory policies for orphan drugs, rare diseases, and ultra-rare diseases.
Read More
Debora Sternaman, PharmD, Discusses the Health Insurance Marketplace
April 4th 2013Debora Sternaman, PharmD, the director of commercial formulary services at Catamaran in Georgetown, TX discusses the Health Insurance Marketplace and how the new model offers a different experience from the current managed care structure.
Read More
Robert W. Dubois, MD, PhD, Describes the Initial Expectations of Accountable Care Organizations
April 4th 2013Robert W. Dubois, MD, PhD, the chief science officer of the National Pharmaceutical Council discusses the initial expectations of implementing accountable care organizations (ACOs) and how those expectations have evolved over time.
Read More
The Advent of Accountable Care Organizations: A Shift in the Managed Care Paradigm
April 4th 2013In a presentation entitled "Accountable Care Organizations: 2013 and Beyond," 4 managed care experts shared their insights and thoughts on the ongoing paradigm shift in managed care towards accountable care organizations, elaborating on current trends, unmet needs, and the future direction of the managed care landscape.
Read More
NOW AVAILABLE: AMCP Fall 2012 Conference Coverage
November 30th 2012Highlights from the Academy of Managed Care Pharmacy's 2012 Educational Conference, which took place on October 3-5, 2012, in Cincinnati, Ohio, are available in a newsletter published by The American Journal of Managed Care. Topics discussed include the ways in which heterogeneity shapes therapeutic decisions, patient outcomes, and coverage policies; assessment of the evidence for new medications; and phone-based medication therapy management services.
Read More
Optimizing Patient Outcomes With Phone-Based Medication Therapy Management Services
October 5th 2012There exists a need for a standard of care to ensure that each patient's medications are appropriate, effective, safe, and able to be taken as intended. Medication therapy management (MTM) is a professional service that can help meet this need. Although the practice of providing comprehensive MTM services by phone has many positive attributes, there are many challenges associated with this type of intervention.
Read More
VIDEO: Brian Sweet, RPh, MBA, Discusses the Integration of Clinical Data Elements and Claims Data
October 5th 2012Brian Sweet, RPh, MBA, Executive Director, Health Care Alliances, AstraZeneca Pharmaceuticals, talks about the progress that has been made to-date in integrating clinical data elements with administrative claims data.
Read More
Evaluating the Value of New Medications Through Evidence-Based Assessments
October 5th 2012Medication assessments directly impact the way a drug is covered, and drugs with better quality data with a higher level of certainty are more favorably covered. Accurately assessing the evidence for new medications will help payers summarize a drug's benefit-to-risk ratio.
Read More
VIDEO: David Nau, PhD, Speaks About The Data Challenges Involved With Medication Adherence Measures
October 4th 2012In this video, David Nau, PhD, talks about data challenges as they relate to medication adherence measures. "One data challenge that Medicare plans face is getting all of the prescription field data from the pharmacist," says Dr. Nau.
Read More
Age-Related Eye Disease: Opportunities for Managed Care Pharmacy
October 4th 2012Managed care pharmacists can help optimize outcomes in patients with age-related eye disease by addressing concerns regarding affordability of therapy, instructing patients on proper eye drop instillation, and evaluating the effects of different therapies. Ophthalmologists and optometrists should take part in managed care formulary discussions to help achieve optimal patient care.
Read More
VIDEO: Mark Zitter, MBA, Discusses Implications of Co-Pay Offset Programs for Managed Care
October 4th 2012In this video, Mark Zitter, MBA, talks about the implications of Co-Pay Offset Programs for managed care. "Co-pay programs affect managed care very differently depending on the nature of the program," says Zitter. "These programs are tremendously varied."
Read More
Deciphering Heterogeneity: Using Clinical Diversity to Improve Drug Therapy Decision Making
October 4th 2012During a preconference session at the Academy of Managed Care Pharmacy (AMCP) 2012 Educational Conference in Cincinnati, Ohio, industry experts met to discuss the ways in which heterogeneity shapes therapeutic decisions, patient outcomes, and coverage policies.
Read More
VIDEO: Beckie Fenrick, PharmD, MBA, Speaks about Oncolytic Therapies
April 20th 2012In this video, Beckie Fenrick, PharmD, MDA, Senior Director, Medical Operations, Care Models and Affordability Solutions, Florida Blue, speaks about oncoloytic therapies. In particular, Fenrick talks about new strategies for managing oncolytic therapies without sacrificing outcomes.
Read More